Related references
Note: Only part of the references are listed.Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis
Ralf Boland et al.
MBIO (2023)
Asp179 in the class A β-lactamase from Mycobacterium tuberculosis is a conserved yet not essential residue due to epistasis
Ilona van Alen et al.
FEBS JOURNAL (2023)
A fresh look at mycobacterial pathogenicity with the zebrafish host model
Monica Varela et al.
MOLECULAR MICROBIOLOGY (2022)
The roles of highly conserved, non-catalytic residues in class A β-lactamases
Aleksandra Chikunova et al.
PROTEIN SCIENCE (2022)
An anti-tuberculosis compound screen using a zebrafish infection model identifies an aspartyl-tRNA synthetase inhibitor
Eva Habjan et al.
DISEASE MODELS & MECHANISMS (2021)
β-lactamase inhibitory potential of kalafungin from marine Streptomyces in Staphylococcus aureus infected zebrafish
Thankaraj Rajam Jabila Mary et al.
MICROBIOLOGICAL RESEARCH (2021)
Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics
Wouter Elings et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
The G132S Mutation Enhances the Resistance of Mycobacterium tuberculosis β-Lactamase against Sulbactam
Ilona van Alen et al.
BIOCHEMISTRY (2021)
Use of Zebrafish in Drug Discovery Toxicology
Steven Cassar et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
Analysis tools to quantify dissemination of pathology in zebrafish larvae
David R. Stirling et al.
SCIENTIFIC REPORTS (2020)
Efficient genome editing in pathogenic mycobacteria using Streptococcus thermophilus CRISPR1-Cas9
Aniek S. Meijers et al.
TUBERCULOSIS (2020)
New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis
Raffaella Tassoni et al.
BIOCHEMISTRY (2019)
Potentiation of P2RX7 as a host-directed strategy for control of mycobacterial infection
Molly A. Matty et al.
ELIFE (2019)
Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer
Fatemeh Bootorabi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Inhibition of the β-Lactamase BlaMab by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus
Anne-Laure Lefebvre et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Protection and pathology in TB: learning from the zebrafish model
Annemarie H. Meijer
SEMINARS IN IMMUNOPATHOLOGY (2016)
β-Lactams against Tuberculosis - New Trick for an Old Dog?
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Zebrafish Breathes new Life into the Study of Tuberculosis
Henna Myllymaki et al.
FRONTIERS IN IMMUNOLOGY (2016)
Paradoxical Hypersusceptibility of Drug-resistant Mycobacterium tuberculosis to β-lactam Antibiotics
Keira A. Cohen et al.
EBIOMEDICINE (2016)
Hydrolysis of Clavulanate by Mycobacterium tuberculosis β-Lactamase BlaC Harboring a Canonical SDN Motif
Daria Soroka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Variants of β-Lactamase KPC-2 That Are Resistant to Inhibition by Avibactam
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
15 years of zebrafish chemical screening
Andrew J. Rennekamp et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2015)
Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma
Molly A. Matty et al.
IMMUNOLOGICAL REVIEWS (2015)
Testing Tuberculosis Drug Efficacy in a Zebrafish High-Throughput Translational Medicine Screen
Anita Ordas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
β-Lactamase inhibition by avibactam in Mycobacterium abscessus
Vincent Dubee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis
Philippe Egesborg et al.
PROTEIN SCIENCE (2015)
Fit for consumption: zebrafish as a model for tuberculosis
Mark R. Cronan et al.
DISEASE MODELS & MECHANISMS (2014)
Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of β-Lactam-β-Lactamase Inhibitor Combinations
Sebastian G. Kurz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish
Kevin Takaki et al.
NATURE PROTOCOLS (2013)
Directed Evolution of Mycobacterium tuberculosis β-Lactamase Reveals Gatekeeper Residue That Regulates Antibiotic Resistance and Catalytic Efficiency
Christian Feiler et al.
PLOS ONE (2013)
Neutrophils Exert Protection in the Early Tuberculous Granuloma by Oxidative Killing of Mycobacteria Phagocytosed from Infected Macrophages
Chao-Tsung Yang et al.
CELL HOST & MICROBE (2012)
Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis
M. C. Payen et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Inter-laboratory assessment of a harmonized zebrafish developmental toxicology assay - Progress report on phase I
A. -L. Gustafson et al.
REPRODUCTIVE TOXICOLOGY (2012)
Mycobacterium marinum Causes a Latent Infection that Can Be Reactivated by Gamma Irradiation in Adult Zebrafish
Mataleena Parikka et al.
PLOS PATHOGENS (2012)
Revisiting the role of the granuloma in tuberculosis
Lalita Ramakrishnan
NATURE REVIEWS IMMUNOLOGY (2012)
Mycobacterium tuberculosis and the intimate discourse of a chronic infection
David G. Russell
IMMUNOLOGICAL REVIEWS (2011)
Three Decades of beta-Lactamase Inhibitors
Sarah M. Drawz et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Taking phage integration to the next level as a genetic tool for mycobacteria
Jason Huff et al.
GENE (2010)
The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection
J. Muse Davis et al.
CELL (2009)
Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis
Timothy P. Stinear et al.
GENOME RESEARCH (2008)
Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish
Hilary Clay et al.
CELL HOST & MICROBE (2007)
Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity
Laura E. Swaim et al.
INFECTION AND IMMUNITY (2006)
Functional characterization of the competence protein DprA/Smf in Escherichia coli
Leonard C. Smeets et al.
FEMS MICROBIOLOGY LETTERS (2006)
Crystal structure and activity studies of the Mycobacterium tuberculosis β-lactamase reveal its critical role in resistance to β-lactam antibiotics
Feng Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
In vitro activity of AVE1330A, an innovative broad-spectrum non-β-lactam β-lactamase inhibitor
A Bonnefoy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Mycobacterium marinum strains can be divided into two distinct types based on genetic diversity and virulence
AM van der Sar et al.
INFECTION AND IMMUNITY (2004)
Clinical role of beta-lactam/beta-lactamase inhibitor combinations
N Lee et al.
DRUGS (2003)
Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis -: Evidence that this lipid is involved in the cell wall permeability barrier
LR Camacho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
